MCCORMICK FRANK 4
4 · BridgeBio Pharma, Inc. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Award
Stock Option (right to buy)
2023-02-21+158,814→ 158,814 totalExercise: $11.92Exp: 2033-02-20→ Common Stock (158,814 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in three annual installments after February 21, 2023, with a final vesting date of February 21, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.